Butterfly Network, Inc. (BFLY)
NYSE:BFLY
Want to see BFLY full AI Analyst Report?
BFLY Stock Chart & Stats
$5.29
-$0.17(-4.21%)
At close: 4:00 PM EST
$5.29
-$0.17(-4.21%)
Day’s Range― - ―
52-Week Range$1.32 - $8.94
Previous CloseN/A
Volume2.30M
Average Volume (3M)6.54M
Market Cap
$2.00B
Enterprise Value$1.38B
Total Cash (Recent Filing)$137.95M
Total Debt (Recent Filing)$19.76M
Price to Earnings (P/E)―
Beta1.83
Next Earnings
Jul 30, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding234,842,770
10 Day Avg. Volume11,290,113
30 Day Avg. Volume6,543,030
Financial Highlights & Ratios
PEG Ratio1.39
Price to Book (P/B)4.79
Price to Sales (P/S)9.62
P/FCF Ratio-58.52
Enterprise Value/Market Cap0.69
Enterprise Value/Revenue13.37
Enterprise Value/Gross Profit27.17
Enterprise Value/Ebitda-20.62
Forecast
1Y Price Target
$5.75Price Target Upside8.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.15
Revenue Forecast (FY)$118.82M
Bulls Say, Bears Say
Bulls Say
Proprietary Ultrasound-on-chip PlatformButterfly's ultrasound-on-chip and handheld POCUS device represent a durable product and IP advantage versus bulky traditional scanners. The single-chip architecture lowers manufacturing complexity, supports scale, enables broader clinical deployment and licensing/Embedded opportunities, creating a long-lived barrier to entry and structural cost benefits for multi-setting adoption.
Regulatory AI Milestone (FDA GA Clearance)Obtaining a precedent-setting FDA AI clearance provides lasting credibility for Butterfly's AI-enabled offerings. It materially de-risks commercialization of Compass AI products, strengthens enterprise and clinical adoption, and supports recurring software revenue streams by validating AI performance and regulatory pathway for future algorithms.
Solid Liquidity And Modest Cash BurnA cash balance near $138M, coupled with improving quarterly cash use (~$12.5M), provides a multi-quarter runway to fund product roadmap, Embedded integrations and Home rollouts without immediate refinancing. That liquidity, alongside modest debt levels noted elsewhere, preserves strategic optionality and supports disciplined scaling.
Bears Say
Persistent Negative Cash Flow & EBITDA LossesDespite improving trends, the company remains meaningfully unprofitable with negative operating and free cash flows and multi‑year adjusted EBITDA losses guided. This structural loss profile requires continued external capital or sustained margin expansion to reach self-sustaining operations and constrains reinvestment flexibility.
Embedded Revenue Concentration & Timing RiskRapid Embedded growth tied to one major partner creates revenue concentration and uncertain delivery timelines. Large, confidential integrations often have long development cycles; reliance on a small number of deals undermines near-term predictability and delays scalable, recurring enterprise software revenue unless diversification accelerates.
EU Regulatory Uncertainty (RoHS Outcome)A shortened RoHS exemption in the EU creates ongoing compliance and market access uncertainty for handheld devices. Interim regulatory restrictions can raise costs, complicate supply chains and slow EU deployments, making European growth and long-term planning less predictable until a stable regulatory resolution is secured.
Butterfly Network News
BFLY FAQ
What was Butterfly Network, Inc.’s price range in the past 12 months?
Butterfly Network, Inc. lowest stock price was $1.32 and its highest was $8.94 in the past 12 months.
What is Butterfly Network, Inc.’s market cap?
Butterfly Network, Inc.’s market cap is $2.00B.
When is Butterfly Network, Inc.’s upcoming earnings report date?
Butterfly Network, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 34 days.
How were Butterfly Network, Inc.’s earnings last quarter?
Butterfly Network, Inc. released its earnings results on Apr 30, 2026. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.049 by $0.019.
Is Butterfly Network, Inc. overvalued?
According to Wall Street analysts Butterfly Network, Inc.’s price is currently Undervalued.
Does Butterfly Network, Inc. pay dividends?
Butterfly Network, Inc. does not currently pay dividends.
What is Butterfly Network, Inc.’s EPS estimate?
Butterfly Network, Inc.’s EPS estimate is -0.04.
How many shares outstanding does Butterfly Network, Inc. have?
Butterfly Network, Inc. has 234,842,770 shares outstanding.
What happened to Butterfly Network, Inc.’s price movement after its last earnings report?
Butterfly Network, Inc. reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.049. Following the earnings report the stock price went down -2.642%.
Which hedge fund is a major shareholder of Butterfly Network, Inc.?
Currently, no hedge funds are holding shares in BFLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Butterfly Network Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.75 (8.70% Upside)
$5.75 (8.70% Upside)
Blogger Sentiment
Bullish
BFLY Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 11.6%
Last 30 Days ▲ 12.1%
Last 30 Days ▲ 12.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
286.56%
12-Months-Change
Fundamentals
Return on Equity
-36.79%
Trailing 12-Months
Asset Growth
-10.20%
Trailing 12-Months
Company Description
Butterfly Network, Inc.
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
BFLY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and commercial highlights — double‑digit revenue growth, margin expansion, meaningful Embedded revenue acceleration, major FDA AI clearance, enterprise software traction and product roadmap visibility — while acknowledging remaining challenges: continued adjusted EBITDA losses, reliance on higher‑end device mix, timing and concentration risks in Embedded and Home rollouts, and regulatory/legal timing in the EU. On balance, the positives (growth, margin improvement, product/regulatory milestones and sizable cash balance) outweigh the lowlights, with management reiterating guidance and emphasizing disciplined investment toward scalable opportunities.View all BFLY earnings summariesBFLY Stock 12 Month Forecast
Average Price Target
$5.75
▲(8.70% Upside)
Technical Analysis
Varex Imaging
―
OrthoPediatrics
―
Bioventus
―
Treace Medical Concepts
―
Ceribell, Inc.
―
Ownership Overview
27.32% Insiders
10.10% Mutual Funds
24.01% Other Institutional Investors
25.79% Public Companies and Individual Investors